Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma

BACKGROUND: Suppressive immune cells present in tumour microenvironments are known to augment tumour growth and hamper efficacy of antitumour therapies. The amino-bisphosphonate Zoledronic acid (ZA) is considered as an antitumour agent, as recent studies showed that ZA prolongs disease-free survival...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Veltman, J D, Lambers, M E H, van Nimwegen, M, Hendriks, R W, Hoogsteden, H C, Hegmans, J P J J, Aerts, J G J V
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2010
Konular:
Translational Therapeutics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2938257/
https://ncbi.nlm.nih.gov/pubmed/20664588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605814
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller